Illumina Inc
Change company Symbol lookup
Select an option...
ILMN Illumina Inc
XPEV Xpeng Inc
PTON Peloton Interactive Inc
PEB Pebblebrook Hotel Trust
VFC VF Corp
BWG BrandywineGLOBAL ? Global Income Opportunities Fund
BPYPO Brookfield Property Partners LP
HLAHU Hamilton Lane Alliance Holdings I Inc
GUERF Guerbet SA
BTCM BIT Mining Ltd
Go

Health Care : Life Sciences Tools & Services | Large Cap Blend
Company profile

Illumina, Inc. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Core Illumina products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. GRAIL is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Customers use its platforms to perform whole genome, de novo, exome and ribonucleic acid (RNA) sequencing, and targeted resequencing of specific gene regions and genes. The Company's BeadArray technology produces arrays that can perform many assays simultaneously. Customers use its array-based genotyping consumables for a range of analyses, including diverse species, disease-related mutations, and genetic characteristics associated with cancer.

Postmarket

Last Trade
Delayed
$217.12
-3.74 (-1.69%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$220.86
Day's Change
2.78 (1.27%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
225.51
Day's Low
216.94
Volume
(Heavy Day)
Volume:
1,395,265

10-day average volume:
974,232
1,395,265

Display:

Providers:

UpdateCancel
6 providers
November 17, 2022
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection

--Approach Informed Development of Galleri(R) Multi-Cancer Early Detection Blood Test --Analysis is Part of Extensive and Systematic Comparison of Cancer Specific Cell-Free DNA Features for Multi-Cancer Early Detection (BusinessWire)

November 15, 2022
Illumina To Webcast Upcoming Investor Conferences

Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conferences: -- Evercore ISI HealthCONx Conference on November 29, 2022Fireside Chat at 8:20am Pacific Time (11:20am Eastern Time) (PR Newswire)

November 03, 2022
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022

-- Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis -- GAAP diluted loss per share of $(24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share...(PR Newswire)

November 02, 2022
ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS

The New Board Members Will Bring Industry Experience to Contribute to Company Growth Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the...(PR Newswire)

Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based...(BusinessWire)

November 01, 2022
Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States

-- Panel leverages precision metagenomics to transform testing for urinary tract infections -- Newest kit follows recent launch of panel testing for 66 viral pathogens that pose persistent threats to global public health (PR Newswire)

October 17, 2022
Illumina to Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022

Illumina, Inc. (NASDAQ: ILMN) today announced that it will host its second annual virtual Environment, Social and Corporate Governance (ESG) focused investor event at 9:30 am Pacific Time (12:30 pm Eastern Time), Friday, October 28, 2022. (PR Newswire)

October 06, 2022
Illumina to Announce Third Quarter 2022 Financial Results on Thursday, November 3, 2022

Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the third quarter 2022 following the close of market on Thursday, November 3, 2022. On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza, Chief...(PR Newswire)

Thinking about trading options or stock in Illumina, Twitter, Apple, Nike, or Hess Corp?

InvestorsObserver issues critical PriceWatch Alerts for ILMN, TWTR, AAPL, NKE, and HES. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027

FinancialNewsMedia.com News Commentary The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix which is due to the abnormal...(PR Newswire)

September 29, 2022
Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum

New sequencing technologies and capabilities will accelerate the genomic discoveries and clinical insights needed to transform human health Revolutionary NovaSeq X Series sets new benchmark for speed, scale, accuracy, and sustainability (PR Newswire)

September 28, 2022
Thinking about trading options or stock in Rio Tinto, Lowe's, Walmart, Illumina, or Exxon Mobil?

InvestorsObserver issues critical PriceWatch Alerts for RIO, LOW, WMT, ILMN, and XOM. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

September 26, 2022
Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via Livestream

Illumina, Inc. (NASDAQ: ILMN) today announced that its inaugural Illumina Genomics Forum, being held in San Diego from September 28 through October 1, is sold out. To accommodate additional interest, on Thursday, September 29, Illumina will host its...(PR Newswire)

September 22, 2022
Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test

First-of-its-kind Galleri(R) Multi-Cancer Early Detection blood test can screen for multiple cancers through a single blood draw. Henry Ford Health, one of the nation's leading academic medical centers recognized for excellence in clinical care...(PR Newswire)

September 19, 2022
Illumina to Host Upcoming Investor Day

Illumina, Inc. (Nasdaq: ILMN) will host its 2022 Investor Day on Monday, October 3rd starting at 8:00am Pacific Time in San Diego, CA. The event will feature presentations by members of Illumina's executive team and conclude with a Q&A session. (PR Newswire)

September 14, 2022
Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications

Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and expertise Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based...(PR Newswire)

September 12, 2022
Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New Infrastructure

The panel will generate ideas and inspiration to build the foundational elements needed to make genomic health equitable, informed, and accountable Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today...(PR Newswire)

September 08, 2022
llumina Announces Opportunity to View Live Webcast of Illumina Genomics Forum Innovation Roadmap Session Followed by Investor Conference Call

Illumina, Inc. (NASDAQ:ILMN) today announced that investors, analysts, and other interested parties may view a live webcast of the Innovation Roadmap session of the Illumina Genomics Forum, which will be hosted by Francis deSouza, Chief Executive...(PR Newswire)

September 07, 2022
Illumina Genomics Forum to Feature Diverse Lineup of Visionary Global Leaders

Full agenda now available for September 28-October 1 event Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of the full agenda for its inaugural Illumina Genomics Forum. The...(PR Newswire)

September 06, 2022
Illumina Intends to Appeal European Commission's Decision in GRAIL Deal

Illumina, Inc. (NASDAQ:ILMN), today received a decision from the European Commission prohibiting the company's acquisition of GRAIL. The company is reviewing the Commission's order and intends to appeal the decision. The EC decision follows last...(PR Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.